In the present study, we investigated the usefulness of sarcopenia as a prognostic biomarker to predict OS in advanced UC patients, along with known prognostic factors such as performance status (PS), anemia, CRP, and the presence of visceral metastasis [13–15]. This evidence concerns the gene CRP and sarcopenia.